Irbesartan and Ischaemia - a phase IV clinical study of FDA data

Summary:

Ischaemia is reported as a side effect among people who take Irbesartan (irbesartan), especially for people who are male, 40-49 old, also take Cellcept, and have Anaemia.

The phase IV clinical study analyzes which people have Ischaemia when taking Irbesartan. It is created by eHealthMe based on reports of 35,908 people who have side effects when taking Irbesartan from the FDA, and is updated regularly.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,414 Irbesartan users. Check the latest studies of Irbesartan.

What is Ischaemia?

Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery) is found to be associated with 643 drugs and 759 conditions by eHealthMe. Check the latest studies of Ischaemia.

On Jul, 26, 2026

35,908 people reported to have side effects when taking Irbesartan.
Among them, 17 people (0.05%) have Ischaemia.

Among these 17 people:

What is the gender of people who have Ischaemia when taking Irbesartan? *

female: 47.06 %
male: 52.94 %

What is the age of people who have Ischaemia when taking Irbesartan? *

What are other drugs people take besides Irbesartan? *

What are other side effects people have besides Ischaemia? *

Hypotension (abnormally low blood pressure): 4 people, 23.53%
Hair Loss: 3 people, 17.65%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 17.65%
Dyspnea (difficult or laboured breathing): 3 people, 17.65%
Diarrhea: 3 people, 17.65%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 3 people, 17.65%
Mitral Valve Incompetence (inefficient heart valve): 3 people, 17.65%
Vaginal Bleeding: 3 people, 17.65%
Anaemia (lack of blood): 3 people, 17.65%
Arrhythmias (irregular heartbeat): 3 people, 17.65%

What are the existing conditions these people have? *

Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 2 people, 11.76%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 11.76%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 11.76%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 2 people, 11.76%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 11.76%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 11.76%
Anaemia (lack of blood): 2 people, 11.76%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
Osteoporosis (bones weak and more likely to break): 1 person, 5.88%
High Blood Cholesterol: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and have Ischaemia?

- Check whether Ischaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Irbesartan:

Irbesartan (36,414 reports)

Ischaemia treatments and more:

Ischaemia (6,386 reports)

Browse all side effects of Irbesartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ischaemia:

Ischaemia (643 drugs)

Browse all the conditions that are associated with Ischaemia:

Ischaemia (759 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on irbesartan (the active ingredients of Irbesartan) and Irbesartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.